Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.

[1]  J. Buring,et al.  Cholesterol and the risk of renal dysfunction in apparently healthy men. , 2003, Journal of the American Society of Nephrology : JASN.

[2]  V. Howard,et al.  Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results. , 2005, Kidney international.

[3]  Hideto Takahashi,et al.  Prognosis of Asymptomatic Hematuria and/or Proteinuria in Men , 2002, Nephron.

[4]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[5]  K. Iseki,et al.  Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. , 2002, Kidney international.

[6]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  F. Port,et al.  Risk factors for proteinuria in a large, multiracial, southeast Asian population. , 2002, Journal of the American Society of Nephrology : JASN.

[8]  J. Buring,et al.  Alcohol consumption and cardiovascular disease mortality in hypertensive men. , 2004, Archives of internal medicine.

[9]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[10]  P. Metcalf,et al.  Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. , 1992, Clinical chemistry.

[11]  J. Saver,et al.  A Quantitative Study , 2005 .

[12]  P. Whelton,et al.  Risk of end-stage renal disease associated with alcohol consumption. , 1999, American journal of epidemiology.

[13]  S. Nakai,et al.  Why has the gross mortality of dialysis patients increased in Japan , 2000 .

[14]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[15]  J. Coresh,et al.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.

[16]  K. Iseki,et al.  Tozawa, M. et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 62, 1743-1749 , 2002 .

[17]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  J. Strong,et al.  Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  K. Iseki,et al.  Body mass index and the risk of development of end-stage renal disease in a screened cohort. , 2004, Kidney international.

[20]  A. Levey.  K/DOQI practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Part 2. Background , 2002 .

[21]  G. Remuzzi,et al.  Progression, remission, regression of chronic renal diseases , 2001, The Lancet.

[22]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[23]  P. Allhoff,et al.  The Honolulu Heart Program , 1991 .

[24]  B. Kasiske,et al.  Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.

[25]  G. Chertow,et al.  The metabolic syndrome and chronic kidney disease , 2006, Current opinion in nephrology and hypertension.

[26]  K. Iseki,et al.  Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[27]  M. Elisaf,et al.  The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study , 2004, Journal of Clinical Pathology.

[28]  K. Iseki,et al.  Influence of smoking and obesity on the development of proteinuria. , 2002, Kidney international.

[29]  S. Adler,et al.  Clinical and demographic predictors of exercise capacity in end-stage renal disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[31]  E. Rimm,et al.  Moderate alcohol intake and renal function decline in women: a prospective study. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  B. Kasiske,et al.  Glomerulosclerosis in aging humans is not influenced by gender. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.

[34]  Hideto Takahashi,et al.  Age distribution and yearly changes in the incidence of ESRD in Japan. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  Giuseppe Remuzzi,et al.  Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. , 2005, Kidney international. Supplement.

[36]  G. Remuzzi,et al.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. , 2006, The Journal of clinical investigation.

[37]  B. Brenner,et al.  From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. , 2004, Kidney international.

[38]  M. Fulker,et al.  Vascular and glomerular changes in the ageing kidney , 1977, The Journal of pathology.

[39]  Smoking and the kidney. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[41]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[42]  S. Olsen,et al.  Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex , 1980, Virchows Archiv A.

[43]  K. Iseki,et al.  Predictors of end-stage renal disease and body mass index in a screened cohort. , 1997, Kidney international. Supplement.

[44]  T. Sairenchi,et al.  Factors affecting renal function in 119 985 adults over three years. , 2001, QJM : monthly journal of the Association of Physicians.

[45]  P. Jungers.  Screening for renal insufficiency: is it worth while? is it feasible? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[47]  A. Dontas,et al.  Mechanisms of renal tubular defects in old age. , 1972, Postgraduate medical journal.